Some Data, Please
By Genome Web,
Genome Web
| 01. 08. 2014
A company and its former subsidiary have settled with the US Federal Trade Commission, which said the companies' advertising claims regarding their genetically tailored nutritional supplements and skincare products were deceptive.
In their marketing material, GeneLink and Foru said that their customized products - customers sent in cheek swabs for genetic analysis - could help overcome genetic shortcomings, according to the FTC. For instance, included testimonials said that the supplements could treat diseases such as diabetes, heart disease, and insomnia, and that the effectiveness of the skin repair serum was scientifically proven. In addition, FTC says the companies did not have appropriate safeguards to ensure the privacy of customers' genetic information, Social Security numbers, and bank account information.
As part of the proposed settlement, the companies would be barred from making claims that their products prevent, treat, or reduce the risk of any disease unless it is true and backed up by at least two well-controlled studies. In addition, any claim saying that a product treats or prevents a disease in someone with certain genetic variation has to be...
Related Articles
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...